Stocks and Investing Stocks and Investing
Tue, January 20, 2015
Fri, January 16, 2015
Thu, January 15, 2015
Wed, January 14, 2015
Tue, January 13, 2015
Mon, January 12, 2015
Sun, January 11, 2015
Fri, January 9, 2015
Thu, January 8, 2015
Wed, January 7, 2015
Tue, January 6, 2015
Mon, January 5, 2015

Christopher Marai Downgraded (BIIB) to Hold and Decreased Target to $378 on, Jan 5th, 2015


Published on 2024-10-25 07:03:09 - WOPRAI, Christopher Marai
  Print publication without navigation


Christopher Marai of Nomura, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $407 to $378 on, Jan 5th, 2015.

Christopher has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Christopher


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $400 on, Wednesday, November 19th, 2014
  • Brian Skorney of "Baird" Upgraded from Hold to Buy on, Wednesday, October 22nd, 2014